2 Popular But Overvalued Biotech Stocks to Avoid

2 Popular But Overvalued Biotech Stocks to Avoid

Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) have been hot stocks this year. At the same time, as rumors swirl regarding the conclusions of each company's phase 3 clinical trials, investors everywhere are hunting for the best competitors in the rapidly expanding coronavirus market. Given that both Moderna and BioNTech have exhibited lightning-fast vaccine development, it's anyone's guess as to which has a better chance of winning the coronavirus vaccine race.